Top-Thema

20.01.17
ROUNDUP/Aktien New York Schluss: Dow erholt sich nach Trump-​Amtsantritt

Novavax to Participate in the Citi 2016 Global Healthcare Conference

Mittwoch, 30.11.2016 22:10

GAITHERSBURG, Md., Nov. 30, 2016 (GLOBE NEWSWIRE) -- Novavax, Inc., (Nasdaq:NVAX) today announced the Company will participate in the Citi 2016 Global Healthcare Conference.

Conference details are as follows:

Date: Wednesday, December 7, 2016
Location: New York Palace Hotel, New York, New York

About Novavax

Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage vaccine company committed to delivering novel products to prevent a broad range of infectious diseases. Our recombinant nanoparticles and Matrix-M(TM) adjuvant technology are the foundation for groundbreaking innovation that improves global health through safe and effective vaccines. Additional information about Novavax is available on the Company's website, novavax.com.

Contact:

Novavax, Inc.
Barclay A. Phillips
SVP, Chief Financial Officer and Treasurer

Andrea N. Flynn, Ph.D.
Associate Director, Investor Relations

ir@novavax.com
240-268-2000

Russo Partners, LLC
David Schull
Todd Davenport, Ph.D.

david.schull@russopartnersllc.com
todd.davenport@russopartnersllc.com
212-845-4271




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Novavax, Inc. via Globenewswire